|
|
|
Axxam is committed to vigilant patent protection in order to safeguard and further strengthen its position as a discovery partner in the life science industry.
Our patent portfolio includes new technologies and tools for High Throughput Screening and detection methods, such as:
- Ca2+ activated photoproteins with improved light generation (Photina® technology)
- a secreted luciferase for reporter gene applications
- green Fluorescence Proteins (GFPs)
- embryonic stem cells that stably express reporter genes such as photoproteins
- transgenic animals capable of in vivo expression of photoproteins (Phototopo®)
- a real-time, non-invasive luminescence-based cAMP detection method
|
|
|
|
|
|
|
